Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-12-18
2007-12-18
Ulm, John (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007210, C436S501000
Reexamination Certificate
active
10509787
ABSTRACT:
A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerize.
REFERENCES:
patent: WO 97/48820 (1997-12-01), None
patent: WO 99/05177 (1999-02-01), None
patent: WO 02/14475 (2002-02-01), None
Bailey et al.; “Patent Status of the therapeutically important G-protein-coupled receptors”,Expert Opin. Ther. Patents11: 1861-1887 (2001).
Barak et al.; “A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation”,The Journal of Biological Chemistry272: 44 27497-27500 (1997).
Bertin et al.; “Cellular signaling by an agonist-activated receptor/G5α fusion protein”,Proc. Natl. Acad. Sci. 91: 8827-8831 (1994).
Chen et al.; “A functional angiotensin II receptor-GFP fusion protein: evidence fro agonist-dependent nuclear translocation”,Am J Physical Renal Physiol279: F440-F448 (2000).
Conway et al.; “Quantitative analysis of Agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate”,J of Celular Phyisiol189: 341-355 (2001).
Coward et al.; “Chimeric G proteins allow a high-throughput signaling assay of Gi-Coupled receptors”Analytical Biochemistry270: 242-248 (1999).
George et al.; “Oligomerization of μ and δ-Opioid receptors”,J of Biological Chemistry275:34 26128-26135 (2000).
George et al.; “G-protein coupled receptor oligomerization and its potential for drug discovery”,Nature1: 808-820 (2002).
Görlich et al.; “Nucleocytoplasmic transport”,Science271: 1513-1518 (1996).
Grötzinger; “Molecular mechanisms of cytokine receptor activation”,Biochimica et Biophysica Acta1592: 215-223 (2002).
Hailey et al.; “Fluorescence resonance energy transfer using color variants of green fluorescent protein”,Methods in Enzymology351: 34-49 (2002).
Hanahan et al.; “Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis”,Cell86: 353-364 (1996).
Howard et al.; “Orphan G-protein-coupled receptors and natural ligand discovery”,Trends in Pharmacological Sciences22:3 132-140 (2001).
Howell et al.; “Live-cell nucleocytoplasmic protein shuttle assay utilizing laser confocal microscopy and FRAP”,BioTechniques32: 80-87 (2002).
Jans et al.; “Nuclear targeting signal recognition: a key control point in nuclear transport?”,BioEssays22: 532-544 (2000).
Lee et al.; “Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets”,Expert Opin. Ther. Targets6: 2 185-202 (2002).
Lee et al.; “Oligomerization of dopamine and serotonin receptors”,Neuropsychopharmacology23: S32-S40 (2000).
Lu et al.; “Angiotensin II-Induced nuclear targeting of the Angiotenin Type 1 (AT1) receptor in brain neurons”,Endocrinology139:1 365-375 (1998).
Masson et al.; “Neurotransmitter transporters in the central nervous system”,Pharmacological Reviews51:3 439-464 (1999).
Matz et al.; “Fluorescent proteins from nonbioluminescent anthozoa species”,Nature Biotechnology17: 969-973 (1999).
Nakae et al.; “Distinct and overlapping functions of insulin and IGF-l receptors”,Endrocrine Reviews22: 6 818-835 (2001).
Nicholson et al.; “EGFR and cancer prognosis”,European Journal of Cancer37: S9-S15 (2001).
O'Dowd et al.; “Short Communication: Discovery of three novel G-protein-coupled receptor genes”,Genomics47: 310-313 (1997).
Prasher et al.; “Primary structure of the Aequorea Victoria green-fluorescent protein”,Gene111: 229-233 (1992).
Schlenstedt; “Protein import into the nucleus”,Fed. Of Europ. Biocehm. Soc. 389: 75-79 (1996).
Shawver et al.; “Smart drugs: tyrosine kinase inhibitors in cancer therapy”,Cancer Cell1: 117-123 (2002).
Smith; “Screening for drug discovery: the leading question”,Nature418: 452-459 (2002)
Strickland et al.; “Diverse roles for the LDL receptor family”,Trends in Endocrinology&Metabolism13: 2 (66-73).
Watson et al.; “Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum0induced cell proliferation”,Bone26:3 221-225 (2000).
Weis; “Importins and exportins: how to get in and out of the nucleus”,TIBS23: 185-189 (1998).
White et al.; “Heterodimerization is required for the formation of a functional GABABreceptor”Nature396: 679-682 (1998).
George Susan R.
O'Dowd Brian F.
Bereskin & Parr
Folkins Patricia
Ulm John
LandOfFree
Method of identifying transmembrane protein-interacting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of identifying transmembrane protein-interacting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of identifying transmembrane protein-interacting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847467